David Lawrence, Chief, Business Operations & PAO at ACORDA THERAPEUTICS INC (ACOR), sold 1,176 shares at $1.60 ($2K) on 2019-12-02, disclosed to the SEC on 2019-12-04.
Scheduled sale ($2k) by Chief, Business Operations & PAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-06-13 | $208K | — | Filing → |
| ACOR | SELL | 2018-06-11 | $1.3M | — | Filing → |
| ACOR | SELL | 2018-01-22 | $1.7M | — | Filing → |